Healthy adults
Conditions
Interventions
Duration: 12 weeks Test material:"
Dose: Take one capsule, three times a day Administration: Take one capsule after each meal
Duration: 12 weeks Test material: Placebo Dose: Take one capsule, three times a day Administration: T
Sponsors
ORTHOMEDICO, Inc.
1. Seishin-kai Medical Association Inc, Takara Medical Clinic. 2. Evaluation Center of Health and Nutrition Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. LDL-cholesterol level was high in the most recent health diagnosis
Exclusion criteria
Exclusion criteria: 1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Currently taking medicines and/or herbal medicines 4. Allergic to medicines or foods related to the test food of this trial 5. Pregnant, lactating, or planning to get pregnant during the trial period 6. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial 7. Judged unsuitable for participating in this trial by physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. LDL-cholesterol *1 Take the blood samples at 0 week and at 6 and 12 weeks after the ingestion | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Total cholesterol, HDL-cholesterol, LDL/HDL ratio, Neutral fat (triglyceride: TG), Free fatty acid, MDA-LDL *1 Take the blood samples at 0 week and at 6 and 12 weeks after the ingestion 2. Body weight, BMI, Body fat percentage *2 Take the measurements at 0 week and at 6 and 12 weeks after the ingestion | — |
Countries
Japan
Contacts
Public ContactNaoko SUZUKI
ORTHOMEDICO, Inc. R&D Department
Outcome results
None listed